Results 31 to 40 of about 14,147 (202)
Lyme disease. Pediatric Aspects (II Part)
Up to 25 % of all patients with Lyme borreliosis — children aged 5–9 years. In children also have three clinical and pathogenetic stages of Lyme disease.
V.V. Mavrutenkov
doaj +1 more source
Gender disparity between cutaneous and non-cutaneous manifestations of Lyme borreliosis.
Cutaneous manifestations of Lyme borreliosis in Europe include erythema migrans (EM) and acrodermatitis chronica atrophicans (ACA); the most common non-cutaneous manifestations are Lyme neuroborreliosis (LNB) and Lyme arthritis. The purpose of this study
Franc Strle +13 more
doaj +1 more source
Update of the Swiss guidelines on post-treatment Lyme disease syndrome. [PDF]
Lyme borreliosis is caused by Borrelia burgdorferi sensu lato infection, which responds well to antibiotic therapy in the overwhelming majority of cases.
C Strahm +14 more
core +3 more sources
Studying the Circulation of Etiological Agent of Lyme Borreliosis in Stavropol Region
Using polymerase chain reaction with reverse transcription (RT-PCR) rRNA tick-borne borreliosis (Lyme borreliosis) etiological agent was detected in suspensions of ticks Ixodes ricinus. Infection rate was 7.1 %.
T. N. Orlova +5 more
doaj +1 more source
A Fatal Case of Late Stage Lyme Borreliosis and Substance Abuse
A recent study demonstrated a 1,100% (12-fold) increase in substance abuse after acquiring Lyme borreliosis. Lyme borreliosis and substance abuse have never been adequately studied and deserves greater attention.
RC Bransfield, ME Embers, AJ Dwork
doaj +1 more source
Borrelia burgdorferi Manipulates Innate and Adaptive Immunity to Establish Persistence in Rodent Reservoir Hosts. [PDF]
Borrelia burgdorferi sensu lato species complex is capable of establishing persistent infections in a wide variety of species, particularly rodents. Infection is asymptomatic or mild in most reservoir host species, indicating successful co-evolution of ...
Baumgarth, Nicole, Tracy, Karen E
core +1 more source
The chemokine CXCL13 in acute neuroborreliosis [PDF]
Objective Recent studies have suggested an important role of the B cell chemoattractant CXCL13 in acute neuroborreliosis (NB). Our aim was to confirm the diagnostic role of CXCL13 and to evaluate its relevance as a therapy response and disease activity ...
Brettschneider, Johannes +5 more
core +3 more sources
Lower Frequency of Multiple Erythema Migrans Skin Lesions in Lyme Reinfections, Europe
The erythema migrans (EM) skin lesion is the most common clinical manifestation of Lyme borreliosis. Information about EM in Lyme borreliosis reinfection is limited.
Franc Strle +8 more
doaj +1 more source
Background In Belgium, different routine surveillance systems are in place to follow-up Lyme borreliosis trends. However, accurate data on the disease and monetary burden for the different clinical manifestations are lacking.
Laurence Geebelen +8 more
doaj +1 more source
In this retrospective study, the performance of nine serological screening assays for Lyme borreliosis (LB) diagnostics was evaluated using a study population of LB cases and controls.
B. J. A. Hoeve-Bakker +9 more
doaj +1 more source

